Patents by Inventor John Griffith Jones

John Griffith Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9322893
    Abstract: The present invention relates to methods of distinguishing between glutamine formed by cataplerosis or proteolysis. Sample from a subject may be assayed for deuteriated glutamine (following administration of deuteriated water (2H2O) and an agent that promotes excretion of glutamine from the subject). The methods are useful in clinical settings (e.g. to test whether or not patients are suffering from proteolysis or whether athletes are abusing anabolic drugs); and may be adapted for screening test compounds for cataplerotic or proteolytic activity.
    Type: Grant
    Filed: May 22, 2009
    Date of Patent: April 26, 2016
    Assignee: BIOCANT-ASSOCIAÇÃO DE TRANSFERÊNCIA DE TECNOLOGIA
    Inventor: John Griffith Jones
  • Publication number: 20110079093
    Abstract: The present invention relates to methods of distinguishing between glutamine formed by cataplerosis or proteolysis. Sample from a subject may be assayed for deuteriated glutamine (following administration of deuteriated water (2H2O) and an agent that promotes excretion of glutamine from the subject). The methods are useful in clinical settings (e.g. to test whether or not patients are suffering from proteolysis or whether athletes are abusing anabolic drugs); and may be adapted for screening test compounds for cataplerotic or proteolytic activity.
    Type: Application
    Filed: May 22, 2009
    Publication date: April 7, 2011
    Applicant: BIOCANT
    Inventor: John Griffith Jones